Press Releases by "Sumitomo Pharma Co., Ltd."

• Dainippon Sumitomo Pharma Co., Ltd. Completes Acquisition of Sepracor Inc. (PDF36kb)
  [ Pharmaceuticals | 2009-10-21]
• Therapeutic agent for hepatocellular carcinoma “MIRIPLA” obtained manufacturing and marketing approval (PDF51kb)
  [ Pharmaceuticals | 2009-10-16]
• Dainippon Sumitomo Pharma Co., Ltd. Completes Tender Offer for Sepracor Inc.(PDF46kb)
  [ Pharmaceuticals | 2009-10-14]
• New OD tablet of AMLODIN by original formulation technology "SUITAB-NEX"(PDF66kb)
  [ Pharmaceuticals | 2009-09-11]
• Dainippon Sumitomo Pharma Co., Ltd. to Acquire U.S.-based Sepracor Inc.(PDF56kb)
  [ Pharmaceuticals | 2009-09-03]
• Acquisition of Sepracor Inc.(PDF315kb)
  [ Pharmaceuticals | 2009-09-03]
• LURASIDONE DEMONSTRATED EFFICACY IN TREATING PATIENTS WITH SCHIZOPHRENIA IN PIVOTAL PHASE 3 STUDY(PDF93kb)
  [ Pharmaceuticals | 2009-08-26]
• Summary of Consolidated Financial Results for the FirstQuarter of the Year Ending March 31, 2010 (PDF 364kb)
  [ Pharmaceuticals | 2009-07-31]
• Announcement of establishment of a holding company in the U.S.(PDF 41kb)
  [ Pharmaceuticals | 2009-06-26]
• Announcement of establishment of a holding company in the U.S.(PDF 41kb)
  [ Pharmaceuticals | 2009-06-26]
• Acquisition of an additional indication of AmBisome, a therapeutic agent for systemic fungal infection(PDF 51kb)
  [ Pharmaceuticals | 2009-06-19]
• STUDY DEMONSTRATING LURASIDONE IS EFFECTIVE IN PATIENTS WITH SCHIZOPHRENIA PUBLISHED IN THE JOURNAL OF CLINICAL PSYCHIATRY(PDF 88kb)
  [ Pharmaceuticals | 2009-06-03]
• DAINIPPON SUMITOMO PHARMA ANNOUNCES LURASIDONE PHASE III DATA IN PATIENTS WITH SCHIZOPHRENIA (PDF 107kb)
  [ Pharmaceuticals | 2009-05-21]
• Supplementary Financial Data For the Year Ended March 31, 2009 (PDF287kb)
  [ Pharmaceuticals | 2009-05-11]
• Summary of Consolidated Financial Results for the Year Ended March 31, 2009 (Unaudited)(PDF307kb)
  [ Pharmaceuticals | 2009-05-11]
• Acquisition of an additional indication relating to pretreatment for barium enema X-ray examination by concomitant use of NIFLEC and GASMOTIN (PDF 63kb)
  [ Pharmaceuticals | 2009-04-22]
• Discontinuation of development of AC-3933, a therapeutic agent for dementia (PDF 37kb)
  [ Pharmaceuticals | 2009-04-17]
• Wakunaga appealed to the Supreme Court against the Osaka High Court’s decision (PDF 40kb)
  [ Pharmaceuticals | 2009-04-09]
• Announcement of a judgment of the suit(an appeal court decision) (PDF 41kb)
  [ Pharmaceuticals | 2009-03-24]
• Launch of "PRONAMID",a gastro-prokinetic agent for dogs (PDF 53kb)
  [ Pharmaceuticals | 2009-03-16]

Most Popular: "Sumitomo Pharma Co., Ltd."